Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
about
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionHepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionClinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patientsTenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialNovel approaches towards conquering hepatitis B virus infection.Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West AfricaLow-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B.HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.Tenofovir-induced kidney injury.Prevalence of hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria.Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.Current treatment of HIV/hepatitis B virus coinfection.Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA.Entecavir exhibits inhibitory activity against human immunodeficiency virus under conditions of reduced viral challenge.HBV and HIV co-infection: Prevalence and clinical outcomes in tertiary care hospital Malaysia.Curative effect of hepatic portal venous administration of autologous bone marrow in AIDS patients with decompensated liver cirrhosis.Screening for and treating hepatitis B virus in patients with HIV infection.
P2860
Q24193121-7BE0E377-3227-4C87-85C6-A2E0B4B740BBQ24198117-E2FC6910-25E3-4EAE-8ACE-372EAD55E6AAQ27488236-1C25547B-3DE7-478D-ADF4-6CC79438D466Q28469218-008A04B6-5BCE-4B52-A0A2-28144E653DB6Q33787687-9E1CF1B0-D616-4051-BBBC-03B719B57B07Q34111234-406BE20A-FAC1-4D0B-839A-57598F28F24EQ34382099-9802AB44-3FA7-4961-99C5-758649A2C989Q36022260-1E68A065-2DAA-4C25-BB6B-D5596487FF64Q36108952-34E78922-BA5A-498A-BE5A-B19AA37A3F5AQ36576503-F2253A03-FE06-4840-9034-36CDF12901C4Q36762441-74C39D57-4F7D-4C09-9038-F05EFBCD1CAAQ36811459-FA45CC3E-1401-4005-9E14-8689A980B1D7Q36873010-1CF23C7F-DBCB-4728-B16F-95FAF4787C2BQ37138048-0CA49CF2-ABEE-4488-8D6D-88BB9EC0F9BEQ37254537-158874C4-F868-4EF0-BD17-4C8F7DDC76D7Q37698987-A4B6F5C9-3732-41A6-B717-9C7226AD9214Q40006328-E924B42B-1901-46BD-94B0-8BBECF5D0175Q40644696-0E09FBA3-038B-423E-BA0C-23F24AED4675Q43065380-79EEEE29-797D-43E3-AF50-7A1E35B5CFB5Q45401313-E8D27330-F48C-493B-B211-A6CA99247E01
P2860
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@ast
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@en
type
label
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@ast
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@en
prefLabel
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@ast
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@en
P356
P1476
Antiretroviral therapy for hep ...... tients: promises and pitfalls.
@en
P2093
Vivian Levy
P304
P356
10.1086/507532
P407
P577
2006-08-23T00:00:00Z